Shanghai Personal Biotechnology Co., Ltd. The company specializes in providing molecular biology technologies and data mining and analysis services in the fields of health medicine and life sciences, including microbiome, genomics, transcriptomics, and protein metabolism. As a national-level high-tech enterprise, Shanghai Personal Biotechnology is recognized as a Little Giant company and holds advantages in intellectual property rights.

Headquartered in Shanghai, the company has multiple wholly-owned subsidiaries and has established a comprehensive gene sequencing platform and big data cloud computing platform. With over 250 authorized patents and software copyrights, its research collaborations have been published in prestigious journals such as Nature and The Lancet. Shanghai Personal Biotechnology's services cover nationwide and extend to Australia, Europe, and the Americas, with offices set up in 28 provinces and cities in China along with collaborations with over 800 global universities, 300 hospitals, and 200 research institutions.

Committed to decoding genetic sequences, interpreting life codes, and improving human lives, Shanghai Personal Biotechnology offers a wide range of solutions in molecular biology research and clinical applications, including high-throughput gene sequencing, clinical genetic testing, protein and metabolic profiling, bioinformatics services, molecular biology experiments, and more